Strides Pharma Science Ltd.

View in App
357.80 -2.35 ▼-0.7%

01 June 2023, 04:01:00 PM
Volume: 12,577

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.strides.com
Market Cap 3,246.83 Cr.
Enterprise Value(EV) 5,705.33 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) -22.44 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-03
Industry PE 32.05 Trailing Twelve Months Ending 2023-03
Book Value / Share 244.98 Trailing Twelve Months Ending 2023-03
Price to Book Value 1.46 Calculated using Price: 357.80
Dividend Yield 0.42 Period Ending 2022-03
No. of Shares Subscribed 9.03 Cr. 90,302,704 Shares
FaceValue 10
About Strides Pharma Science Ltd.
The company's core competence is in the development and manufacture of wide range of niche and technically complex pharmaceutical products. The company is also among the world's largest soft gelatin capsule manufacturers.

Strides Pharma Science Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Strides Pharma Science Ltd. Performance

View details >>
1 Day
-0.65%
1 Week
-1.39%
1 Month
+5.07%
3 Month
+20.72%
6 Month
+4.38%
1 Year
+8.79%
2 Year
-53.11%
5 Year
-7.21%
10 Year
-59.26%

Strides Pharma Science Ltd. Fundamental Ratios

View details >>
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -15.37 0.09 6.22 10.37 2.86 3.50 1.68 9.21 -18.49
Return on Capital Employed (%) 7.76 10.92 7.98 8.32 4.83 2.61 4.06 9.08 -9.49
Return on Assets (%) -6.76 0.04 2.40 3.63 1.02 1.24 0.63 3.82 -6.99

Strides Pharma Science Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 1,007 1,145 2,658 2,749 2,464 2,649 2,527 2,777 2,359 2,212
Non Curr. Liab. 306 286 2,760 2,049 2,067 2,343 814 1,264 966 1,210
Curr. Liab. 707 1,020 1,892 3,104 1,899 2,662 2,545 2,738 3,412 2,990
Minority Int. 76 19 50 134 155 153 67 37 24 -39
Equity & Liab. 2,096 2,469 7,360 8,035 6,585 7,807 5,953 6,817 6,761 6,373
Non Curr. Assets 788 1,040 3,845 4,243 4,101 4,758 3,581 4,000 3,399 3,130
Curr. Assets 1,309 1,429 3,515 3,792 2,447 3,049 2,371 2,817 3,362 3,243
Misc. Exp. not W/O
Total Assets 2,096 2,469 7,360 8,035 6,585 7,807 5,953 6,817 6,761 6,373

Strides Pharma Science Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 1,341 1,196 2,862 2,755 2,845 2,178 2,752 3,316 3,070 3,688
Other Income 60 39 92 161 76 41 53 59 132 113
Total Income 1,401 1,234 2,954 2,917 2,921 2,219 2,805 3,375 3,202 3,802
Total Expenditure -1,118 -967 -2,448 -2,228 -2,431 -1,936 -2,236 -2,689 -3,090 -3,281
PBIDT 284 267 506 688 491 283 569 686 112 521
Interest -109 -47 -168 -183 -196 -79 -156 -150 -177 -261
Depreciation -56 -64 -131 -126 -154 -117 -174 -206 -233 -243
Taxation -325 -148 -42 -63 -6 27 -11 -32 178 55
Exceptional Items -27 -7 -41 -36 -44 22 -78 43 -244 -17
PAT -233 1 118 280 74 89 43 244 -474 54
Minority Interest -1 1 14 -46 -20 -5 6 11 14 10
Share Associate -285
Other Related Items
Consolidated Net Profit 1,767 845 109 400 665 325 36 268 -460 -203
Adjusted EPS 297 142 12 45 74 36 4 30 -51 -23

Strides Pharma Science Ltd. Cash Flow

View details >>
Particulars 10 years 2012-12 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 134 -272 83 73 288 187 60 205 481 -258
Cash Fr. Inv. 807 4,077 52 -2,225 -687 583 -148 1,306 -521 -119
Cash Fr. Finan. -990 -3,319 -421 2,944 338 -1,016 194 -1,709 -16 421
Net Change -49 487 -286 792 -60 -246 106 -199 -55 45
Cash & Cash Eqvt 132 586 298 1,111 515 256 366 182 126 171

Strides Pharma Science Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 29.67 29.62 29.60 29.60 30.60 30.37 31.07 30.89 28.27
Public 70.33 70.38 70.40 70.40 69.40 69.63 68.93 69.11 71.73
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 32.56 26.02 26.02 37.84 56.67 62.20 69.42 69.44 81.80

Strides Pharma Science Ltd. Announcements

View details >>
Thu, 01 Jun 2023
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Earnings Call transcript pertaining to Audited Financial Results for the quarter and year ended March 31 2023.
Tue, 30 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the year ended March 31 2023
Fri, 26 May 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement - Audited Financial Results for the quarter and year ended March 31 2023

Strides Pharma Science Ltd. Technical Scans

View details >>
Thu, 01 Jun 2023
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Opening at Low Opening at Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months

Strides Pharma Science Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 236,934.33 987.50 +1.1%
Divi's Laboratories Ltd. 93,571.04 3,524.75 +2.1%
Cipla Ltd. 77,836.62 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. 75,790.17 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. 69,284.07 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. 60,079.14 1,775.15 -3.8%
Mankind Pharma Ltd. 56,008.27 1,398.15 +2.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 27.96 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2023-03 51.32 3,524.75 +2.1%
Cipla Ltd. Consolidated 2023-03 27.78 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 16.82 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 84.60 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 48.26 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 41.95 1,398.15 +2.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.23 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2023-03 7.33 3,524.75 +2.1%
Cipla Ltd. Consolidated 2023-03 3.33 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.25 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.19 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.69 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 5.39 1,398.15 +2.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,524.75 +2.1%
Cipla Ltd. Consolidated 2022-03 0.04 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,398.15 +2.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,524.75 +2.1%
Cipla Ltd. Consolidated 2022-03 13.10 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,398.15 +2.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,524.75 +2.1%
Cipla Ltd. Consolidated 2022-03 13.10 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,398.15 +2.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,524.75 +2.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,398.15 +2.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,524.75 +2.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,398.15 +2.9%

Strides Pharma Science Ltd. FAQ's

What is Strides Pharma Scien share price?
Can I buy Strides Pharma Scien shares now?
What is the Dividend Yield of Strides Pharma Scien?
What is the Market Cap of Strides Pharma Scien?
What are the key metrics to analyse Strides Pharma Scien?
What is the 52 Week High and Low of Strides Pharma Scien?
What is the trend of Strides Pharma Scien share price?